Top Markets
#1 Black Phoenix Black Phoenix +17,849.79%
#2 Cash Dog in Hood Cash Dog in Hood +6,497.44%
#3 AgentFun.AI AgentFun.AI +54.83%
#4 up up +51.83%
#5 Arrow Arrow +50.00%
#6 Quai Network Quai Network +39.61%
#7 Octra Octra +37.18%
#8 Derive Derive +34.26%
#9 B3 (Base) B3 (Base) +29.84%
#10 Block Street Block Street +28.94%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rank in Stocks #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Share Price
$4.66
Market Cap
$43.92M
Change (1 day)
-0.63%
Change (1 year)
338.04%
Country
FR
Trade Theranexus Société Anonyme (ALTHX)

Category

Healthcare
P/B ratio for Theranexus Société Anonyme (ALTHX)
P/B ratio as of July 2026 TTM: 23.01
According to Theranexus Société Anonyme latest financial reports and stock price the company's current price-to-book ratio (TTM) is 23.01. At the end of 2023 the company had a P/B ratio of 3.91.
P/B ratio history for Theranexus Société Anonyme from 2015 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 23.01 -872.06%
2024 -2.98 -176.13%
2023 3.91 140.89%
2022 1.62 -32.16%
2021 2.39 -67.52%
2020 7.37 537.01%
2019 1.16 -73.36%
2018 4.34 72.54%
2017 2.52 -98.37%
2016 154.33 1,766.00%
2015 8.27 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 6.8826 -70.09%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5189 -71.67%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.0637 -91.03%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5808 -80.09%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.7629 -66.26%
NL